<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001801917</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001635088</issuerCik>
      <issuerName>Roivant Sciences Ltd.</issuerName>
      <secFileNumber>001-40782</secFileNumber>
      <issuerAddress>
        <com:street1>7TH FLOOR, 50 BROADWAY</com:street1>
        <com:city>LONDON</com:city>
        <com:stateOrCountry>X0</com:stateOrCountry>
        <com:zipCode>SW1H 0DB</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>441-295-5950</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Venker Eric</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Rockefeller Financial LLC</name>
        <address>
          <com:street1>45 Rockefeller Plaza</com:street1>
          <com:street2>Floor 5</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10111</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>200000</noOfUnitsSold>
      <aggregateMarketValue>6631659.08</aggregateMarketValue>
      <noOfUnitsOutstanding>719270385</noOfUnitsOutstanding>
      <approxSaleDate>06/24/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <acquiredDate>06/24/2026</acquiredDate>
      <natureOfAcquisitionTransaction>Options Exercise - Grant Date 04/20/2022</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>200000</amountOfSecuritiesAcquired>
      <paymentDate>06/24/2026</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Eeric Venker c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor, 50 Broadway</com:street1>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>04/20/2026</saleDate>
      <amountOfSecuritiesSold>200000</amountOfSecuritiesSold>
      <grossProceeds>5917134.05</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Eric Venker c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor, 50 Broadway</com:street1>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>05/22/2026</saleDate>
      <amountOfSecuritiesSold>200000</amountOfSecuritiesSold>
      <grossProceeds>6054730.92</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/28/2025.</remarks>
    <noticeSignature>
      <noticeDate>06/24/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>03/28/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Venker Eric</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
